-
Document de presse | 2016.11.03
Diagnosis of Alzheimer's disease: llama antibodies detect cerebral lesions
The major challenge facing physicians treating Alzheimer's is the ability to detect markers of the disease as early as possible. These markers, located in the brain, are difficult to access, hampering diagnosis. Using two types of llama antibody capable of crossing the blood-brain barrier, scientists from the Institut Pasteur, Inserm, the CNRS, the CEA, Pierre & Marie Curie and Paris...
-
Document de presse | 2016.09.22
Sleeping sickness: parasites found hiding in the skin
Scientists from the Trypanosome Cell Biology Unit (Institut Pasteur/Inserm), working in collaboration with scientists from the University of Glasgow, have demonstrated the presence of a large quantity of trypanosomes – the parasites responsible for sleeping sickness – in the skin of individuals with no symptoms. This discovery should refocus the screening strategy for this disease,...
-
Document de presse | 2016.11.08
The ADITEC Project on Advanced Immunization Technologies: an European Success Story
30 million Euros of funding, 42 public and private institutions have joined forces for next generation vaccines.The ADITEC project was presented today at the European Parliament as a Success Story.Development of novel immunisation technologies, adjuvants, vectors and delivery systems, formulations and vaccination methods optimised for different age groups, 207 scientific publications, and...
-
Document de presse | 2016.11.04
Malaria – Discovery of a molecular marker associated with piperaquine resistance in parasites
A collaborative project conducted by scientists from the Institut Pasteur in Cambodia, the Institut Pasteur in Paris, the Institut Cochin, the Laboratory of Applied Mathematics at Paris Descartes University, Columbia University (New York, USA) and the National Malaria Control Program in Cambodia has identified a molecular marker able to detect Plasmodium falciparum malaria parasites resistant to...
-
Document de presse | 2016.09.19
Too much fat rapidly disrupts the balance of the gut microbiota
A destabilizing factor such as a change in diet can disrupt the entire gut microbiota, with possible health consequences. An international study led by the Molecular Microbial Pathogenesis Unit (Institut Pasteur/Inserm), directed by Philippe Sansonetti, has recently demonstrated in mice that a high-fat diet has a direct influence on the gut microbiota and its environment. Bacterial communities...
-
Page avancée | 2016.11.10
History
History
-
Article | 2016.11.10
The early years 1847-1862
In 1847 Louis Pasteur, a young chemist freshly graduated from the prestigious Ecole normale supérieure, set to work on the problem posed by German physicist Eilhard Mitscherlich, namely, why do sodium ammonium paratartrate and tartrate - two seemingly identical chemical substances - affect polarized light differently ?
-
Article | 2016.11.10
The middle years 1862-1877
Louis Pasteur’s work raised a new set of research questions, such as " Where do fermentation agents come from ? " and " Do they originate from germs similar to themselves or do they appear spontaneously as explained by the spontaneous generation theory ? "
-
Article | 2016.11.10
The final years 1877-1887
Between the age of 55 and 65 Louis Pasteur developed microbiology, applying it to medicine and surgery. Having established that diseases were caused by microorganisms, he then sought to identify and find a means of fighting them. His finest accomplishment was rabies.
-
Article | 2016.11.15
Alphonse Laveran (1845-1922)
Alphonse Laveran was France’s first Nobel laureate in Physiology or Medicine. He discovered the parasite that causes malaria.
